Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Thomson ISI, 2012. Shirin Hasani-Ranjbar, Somayeh Khosravi, Neda Nayebi, Bagher Larijani and Mohammad Abdollahi. Asian Journal of Animal and Veterinary Advances, 7(8), pp.621-640.

  View at Publisher | View at Google Scholar

• Baeeri M, Momtaz S, Navaei-Nigjeh M, Niaz K, Rahimifard M, et al. 2017. Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells. Food and Chemical Toxicology, 100, pp.8-23.

  View at Publisher | View at Google Scholar

• Hasani-Ranjbar S, Nayebi N, Larijani B and Abdollahi M, 2009. Citation of This Article Corresponding Author of This Article Keywords for Related Literature of This Article Article-Type of This Article Open-Access Policy of This Article. World J Gastroenterol, 15(25), pp.3073-3085.

  View at Publisher | View at Google Scholar

• Abdollahi M, 2012. A comprehensive review of biochemical and molecular evidences from animal and human studies on the role of oxidative stress in aging: an epiphenomenon or the cause.

  View at Publisher | View at Google Scholar

• Kumari A, Chandra R, Dang AK, Manjari P, Kumari R, et al. 2016. Effects of supplementation of polyherbal-potash alum mixture on immune status of crossbred cows during transition period. Indian Journal of Animal Research.

  View at Publisher | View at Google Scholar

• Sharma HK, Gogoi B and Nainwal LM, A Review on Some Antioxidant Plant Species Growing in North East India.

  View at Publisher | View at Google Scholar

• Zhang Y, Liu M, Jiang S, Wu A, Chen X, et al. 2014.A Study on the Factors Affecting the Quality of Life of Osteoporosis in Elderly Women in Wenzhou Region. Guangdong Journal of Trace Element Science, 21 (3), pp.17-23.

  View at Publisher | View at Google Scholar

• Barritt AW and Smithard DG, 2009. Role of cerebral cortex plasticity in the recovery of swallowing function following dysphagic stroke. Dysphagia, 24(1), pp.83-90.

  View at Publisher | View at Google Scholar

• Krival K, 2013. Clinical Consideration of Oral and Related Sensory Processing and Dysphagia. SIG 13 Perspectives on Swallowing and Swallowing Disorders (Dysphagia), 22(3), pp.94-106.

  View at Publisher | View at Google Scholar

• Smithard D and Weekes CE, 2015. Swallowing and Nutritional Complications. In Management of Post-Stroke Complications (pp. 99-155). Springer International Publishing.

  View at Publisher | View at Google Scholar

• Miller KB, Nestec SA, 2014. Treatment of oral pharyngeal dysphagia. U.S. Patent 8,871,281.

  View at Publisher | View at Google Scholar

• Smithard DG, 2016. Dysphagia Management and Stroke Units. Current Physical Medicine and Rehabilitation Reports, 4(4), pp.287-294.

  View at Publisher | View at Google Scholar

• Akhoondzadeh SH and Kashani L, 2006. Psychiatric disorders and pregnancy. Tehran University Medical Journal TUMS Publications, 64(5), pp.5-14.

  View at Publisher | View at Google Scholar

• Singh PM, Kaur M and Trikha A, 2013. An uncommonly common: glossopharyngeal neuralgia. Annals of Indian Academy of Neurology, 16(1), p.1.

  View at Publisher | View at Google Scholar

• Kim SH, Han KR, Kim DW, Lee JW, Park KB, et al. 2010. Severe pain attack associated with neurocardiogenic syncope induced by glossopharyngeal neuralgia: successful treatment with carbamazepine and a permanent pacemaker-a case report. The Korean journal of pain, 23(3), pp.215-218.

  View at Publisher | View at Google Scholar

• Stapelberg NJ, Hamilton-Craig I, Neumann DL, Shum DH, McConnell H (2012) Mind and heart: heart rate variability in major depressive disorder and coronary heart disease-a review and recommendations. Australian & New Zealand Journal of Psychiatry 46: 946-57.

  View at Publisher | View at Google Scholar

• Alafaci C, Granata F, Cutugno M, Marino D, Conti A, et al. 2015. Glossopharyngeal neuralgia caused by a complex neurovascular conflict: case report and review of the literature. Surgical neurology international, 6.

  View at Publisher | View at Google Scholar

• Sander GE, Giles TD (2011) Resistant hypertension: concepts and approach to management. Current hypertension reports 13: 347.

  View at Publisher | View at Google Scholar

• Alafaci C, Grasso G, Granata F, Cutugno M, Marino D, et al. 2015. Surgical Neurology International.

• Younis M, Iqbal M, Shoukat N, Abbas R, Wattoo FH, et al. (20140 Chemotherapy and radiotherapy, a cause of hypertension and weight loss in cancer patients. SCIENCE LETTERS 2: 53-55.

  View at Publisher | View at Google Scholar

• Harikrishnan K, Anjaly S, Kuriakose MC, Prasad B, Govind B, et al. 2015. A case study on wiesenberg syndrome. International Journal of Bioassays, 4(07), pp.4131-4133.

  View at Publisher | View at Google Scholar

• McLaughlin AN, Policarpo G (2012) Hypertension in cancer patients. Community Oncology 9: 324-330.

  View at Publisher | View at Google Scholar

• Giles TD (2011)Aspects of some complex issues in hypertension. Therapy 8: 209-210.

  View at Publisher | View at Google Scholar

• Barendrecht MM, Abrams P, Schumacher H, de la Rosette JJ and Michel MC, 2008. Do α1‐adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?. Neurourology and urodynamics, 27(3), pp.226-230.

  View at Publisher | View at Google Scholar

• Landefeld K, Gonzales H, Sander GE (2016) Hypertensive Crisis: The Causative Effects of Nonsteroidal Anti-Inflammatory Drugs. J Clin Case Rep 6: 2.

  View at Publisher | View at Google Scholar

• Franco-Salinas G, de la Rosette JJ and Michel MC, 2010. Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. Clinical pharmacokinetics, 49(3), pp.177-188.

  View at Publisher | View at Google Scholar

• Altan-Yaycioglu R, Yaycioglu O, Gul U, Pelit A, Adibelli FM, et al. 2007. The effects of two systemic α1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study. Naunyn-Schmiedeberg's archives of pharmacology, 375(3), pp.199-203.

  View at Publisher | View at Google Scholar

• Michel MC, 2010. The pharmacological profile of the α 1A-adrenoceptor antagonist silodosin. European Urology Supplements, 9(4), pp.486-490.

  View at Publisher | View at Google Scholar

• Hirschhorn LR, Newell ML (2007) Challenges and opportunities for expanding HIV care and treatment: what can be. Therapy 4: 701-703.

  View at Publisher | View at Google Scholar

• Schulman CC, 2008. Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Expert opinion on drug metabolism & toxicology, 4(6), pp.771-782.

  View at Publisher | View at Google Scholar

• Zewdie D, Cahn P, McClure C, Bataringaya J (2008) The role of HIV research in building health system capacity in developing countries. Current Opinion in HIV and AIDS 3: 481-488.

  View at Publisher | View at Google Scholar
• Gadzhieva ZK, Alyaev YG And Vinarov AZ. On the features of the choice of drug therapy for obstructive diseases of the lower urinary tract. View at Publisher | View at Google Scholar

• Hirschhorn LR, Newell ML (2007) Challenges and opportunities for expanding HIV care and treatment: what can be. Therapy. 4: 701-703.

  View at Publisher | View at Google Scholar

• Sivkov AV, Keshishev NG, Romich VV, Malyshev AV, Gonzalez EN, et al. Efficacy of silodosin in patients with severe symptoms of lower urinary tract function disorder due to BPH.

  View at Publisher | View at Google Scholar

• Alyaev YG, GADZHIEVA ZK, Rapoport LM and Kazilov YB, 2014. Drug treatment of symptoms of the lower urinary tract in men. The role of uroselectivity in the choice of the drug. Andrology and genital surgery, (1).

  View at Publisher | View at Google Scholar

• Karabulut GS, BeÅŸer ÖF, Erginöz E, Kutlu T, ÇokuÄŸraÅŸ FÇ,et al (2013) The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment. Journal of neurogastroenterology and motility 19: 90-93.

  View at Publisher | View at Google Scholar

• Grynkiewicz G and Gadzikowska M, 2008. Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. Pharmacol Rep, 60(4), pp.439-463.

  View at Publisher | View at Google Scholar

• Giannetti E, de'Angelis G, Turco R, Campanozzi A, Pensabene L (2014) Salvatore S, de Seta F, Staiano A. Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up. The Journal of pediatrics 164: 1099-1103.

  View at Publisher | View at Google Scholar

• Jirschele K and Sand PK, 2013. Oxybutynin: past, present, and future. International urogynecology journal, 24(4), pp.595-604.

  View at Publisher | View at Google Scholar

• Stabell N, Stubhaug A, Flægstad T, Mayer E, Naliboff BD, et al. (2014) Widespread hyperalgesia in adolescents with symptoms of irritable bowel syndrome: results from a large population-based study. The Journal of Pain 15: 898-906.

  View at Publisher | View at Google Scholar

• Varni JW, Shulman RJ, Self MM, Nurko S, Saps M, et al. (2015) Symptom profiles in patients with irritable bowel syndrome or functional abdominal pain compared with healthy controls. Journal of pediatric gastroenterology and nutrition 61: 323-329.

  View at Publisher | View at Google Scholar

• Varni JW, Nurko S, Shulman RJ, Self MM, Saps M, et al. (2015) Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared With Healthy Controls. Journal of pediatric gastroenterology and nutrition. 61: 424-430.

  View at Publisher | View at Google Scholar

• Saps M, Velasco-Benítez C, Kovacic K, Chelimsky G, Kovacic K, et al. (2016) High prevalence of nausea among school children in Latin America. The Journal of pediatrics 169: 98-104.

  View at Publisher | View at Google Scholar

• Silverman LR, Fenaux P, Mufti GJ, Santini V, Hellström‐Lindberg E, et al. (2011) Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes. Cancer, 117(12), pp.2697-2702.

  View at Publisher | View at Google Scholar

• Platonov OM (2013) Features of the functional state of the vegetative nervous system in children with irritable bowel syndrome. Bukovynskiy Medical Journal 17: 67.

  View at Publisher | View at Google Scholar

• Horvath A, Dziechciarz P, DżygaÅ‚o K, Dybkowska S (2012) Prevalence of functional gastrointestinal pain-related disorders in children and adolescents with type 1 diabetes. Gastroenterologia Polska/Gastroenterology. 19.

  View at Publisher | View at Google Scholar

• Garcia-Manero G, Gore SD, Cogle C, Ward R, Shi T, et al. (2011) Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Journal of Clinical Oncology, 29(18), pp.2521-2527.

  View at Publisher | View at Google Scholar

• Deacy AD, Morrison C (2015) Understanding and treatment of chronic abdominal pain among school nurses: A national survey. Clinical Practice in Pediatric Psychology 3: 288.

  View at Publisher | View at Google Scholar

• Smartt P and Campbell-Page R, (2009) Horizon scanning report.

  View at Publisher | View at Google Scholar

• Oberlander TF, Zeltzer L. Douleur chez l’enfant autiste. InSanté mentale et douleur 2013 (pp. 173-197). Springer Paris.

  View at Publisher | View at Google Scholar